2025-08-08 20:32:31
Latest Post
Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
RBI grants NBFC license to Equirus Group
Stock Report
Nikhil Adhesives Ltd reports net profit of Rs. 2.89 crore in Q3FY23
Posted On : 2023-02-07 19:30:26( TIMEZONE : IST )
has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 161.9030 crores during the period ended December 31, 2022 as compared to Rs. 196.8370 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. 2.8983 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 4.2304 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. 0.63 for the period ended December 31, 2022 as compared to Rs. 0.92 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹161.9030 crs | ₹196.8370 crs |  -17.75% |
| Net Profit | ₹2.8983 crs | ₹4.2304 crs | -31.49% |
| EPS | ₹0.63 | ₹0.92 | -31.52% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.161.9030 crores during the period ended December 31, 2022 as compared to Rs.221.3542 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.2.8983 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.5.8161 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.0.63 for the period ended December 31, 2022 as compared to Rs.1.27 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹161.9030 crs | ₹221.3542 crs | -26.86% |
| Net Profit | ₹2.8983 crs | ₹5.8161 crs | -50.17% |
| EPS | ₹0.63 | ₹1.27 | -50.39% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.583.1590 crores during the 9 Months period ended December 31, 2022 as compared to Rs.596.0880 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.13.4103 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.19.1355 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.2.92 for the 9 Months period ended December 31, 2022 as compared to Rs.4.17 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹583.1590 crs | ₹596.0880 crs | -2.17% |
| Net Profit | ₹13.4103 crs | ₹19.1355 crs | -29.92% |
| EPS | ₹2.92 | ₹4.17 | -29.98% |
